The BLS Polymers IPO is an upcoming mainboard Bookbuilding offer (Fresh capital only) scheduled to open on 27 October 2026. The BLS Polymers IPO will close on 29 October 2026, with an issue price of ₹150 per share. The BLS Polymers IPO has a face value of ₹10 and a lot size of 100 shares. The BLS Polymers IPO size aggregates up to ₹255 crore, listing on NSE & BSE on 3 November 2026. The BLS Polymers IPO allotment is expected on 30 October 2026.
On the financial front, the BLS Polymers IPO reported revenue of ₹108 crore for 30 Jun 2026, compared with ₹354 crore for 31 Mar 2026. The BLS Polymers IPO PAT was ₹10 crore against ₹27 crore. The BLS Polymers IPO EBITDA stood at ₹16 crore with a 15.15% margin. The BLS Polymers IPO net worth as of 30 Jun 2026 was ₹105 crore.
Always verify The BLS Polymers IPO details and GMP data with the official offer document before investing in the BLS Polymers IPO.
Financial Summary
Amount in ₹ Crore
Metric
30 Jun 2026
31 Mar 2026
31 Mar 2025
Total Assets
231
206
179
Revenue
108
354
337
PAT
10
27
21
EBITDA
16
47
40
Net Worth
105
95
68
Reserves
60
50
58
Total Borrowing
63
52
74
BLS Polymers IPO Financials FAQs
Revenue of BLS Polymers (Amount in ₹ Crore) — 30 Jun 2026: 108; 31 Mar 2026: 354; 31 Mar 2025: 337. Profit after tax (PAT) — 30 Jun 2026: 10; 31 Mar 2026: 27; 31 Mar 2025: 21.
EBITDA of BLS Polymers (Amount in ₹ Crore) — 30 Jun 2026: 16; 31 Mar 2026: 47; 31 Mar 2025: 40. The EBITDA margin is 15.15%.
Total assets — 30 Jun 2026: 231; 31 Mar 2026: 206; 31 Mar 2025: 179. Net worth — 30 Jun 2026: 105; 31 Mar 2026: 95; 31 Mar 2025: 68. Reserves & surplus — 30 Jun 2026: 60; 31 Mar 2026: 50; 31 Mar 2025: 58. (Amount in ₹ Crore)
Total borrowing of BLS Polymers (Amount in ₹ Crore) — 30 Jun 2026: 63; 31 Mar 2026: 52; 31 Mar 2025: 74. Debt-to-equity ratio: 0.61.
The financials shown for BLS Polymers IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
